tranexamic acid has been researched along with Bright Disease in 6 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent data indicated that aging accelerated glomerular fibrin deposition induced by lipopolysaccharide (LPS) in mice." | 3.73 | Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages. ( Chen, X; Feng, Z; Hong, Q; Lin, S; Lu, Y; Shi, S; Sun, X; Wang, J; Xi, C, 2005) |
| "Tranexamic acid is a potent antifibrinolytic drug frequently used in the treatment of haematuria and a number of other haemorrhagic conditions." | 1.26 | Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. ( Andersson, L; Eriksson, O; Hedlund, PO; Kjellman, H; Lindqvist, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Revollo, JY | 1 |
| Cuffy, MC | 1 |
| Witte, DP | 1 |
| Paterno, F | 1 |
| Alloway, RR | 1 |
| Woodle, ES | 1 |
| Kitamura, H | 1 |
| Matsui, I | 1 |
| Itoh, N | 1 |
| Fujii, T | 1 |
| Aizawa, M | 1 |
| Yamamoto, R | 1 |
| Okuno, A | 1 |
| Okazaki, Y | 1 |
| Fujita, Y | 1 |
| Kuwayama, Y | 1 |
| Imai, E | 1 |
| Fujii, M | 1 |
| Xi, C | 1 |
| Chen, X | 1 |
| Sun, X | 1 |
| Shi, S | 1 |
| Feng, Z | 1 |
| Wang, J | 1 |
| Hong, Q | 1 |
| Lu, Y | 1 |
| Lin, S | 1 |
| Huang, Y | 1 |
| Border, WA | 1 |
| Lawrence, DA | 1 |
| Noble, NA | 1 |
| Andersson, L | 1 |
| Eriksson, O | 1 |
| Hedlund, PO | 1 |
| Kjellman, H | 1 |
| Lindqvist, B | 1 |
| Foster, GR | 1 |
| Carmichael, DJ | 1 |
| Kermode, A | 1 |
| Hulme, B | 1 |
| Gabriel, JR | 1 |
| Cattell, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery: A Double Blind Randomized Controlled Trial[NCT01111669] | 28 participants (Actual) | Interventional | 2009-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for tranexamic acid and Bright Disease
| Article | Year |
|---|---|
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu | 2015 |
Tranexamic acid-induced visual impairment in a hemodialysis patient.
Topics: Angiography; Antifibrinolytic Agents; Drug Overdose; Glomerulonephritis; Humans; Male; Middle Aged; | 2003 |
Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages.
Topics: Aging; Animals; Antifibrinolytic Agents; Antigens, CD; Blotting, Northern; Cadherins; Chemokine CCL2 | 2005 |
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Topics: Animals; Antifibrinolytic Agents; Cells, Cultured; Collagen Type I; Extracellular Matrix; Fibrinolys | 2006 |
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
Topics: Biological Availability; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; Glomerulonephriti | 1978 |
Extensive crescent formation with antifibrinolytic therapy in a case of diffuse endocapillary glomerulonephritis.
Topics: Acute Disease; Acute Kidney Injury; Cyclohexanecarboxylic Acids; Female; Glomerulonephritis; Humans; | 1990 |